← Browse by Condition
Medical Condition
metastatic prostate cancer
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 2, Phase 3
NCT00923221
Recruiting
Collection of Blood From Patients With Prostate Cancer
Enrollment
1,000 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT07290270
Recruiting
Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN)
Enrollment
170 pts
Location
China
Sponsor
Novartis Pharmaceuticals
NCT06582628 Phase 2
Recruiting
Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)
Enrollment
78 pts
Location
Spain
Sponsor
Fundacion Oncosur
NCT06112990 Phase 3
Recruiting
Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression
Enrollment
200 pts
Location
United States
Sponsor
University of Utah
NCT05404139 Phase 2
Recruiting
Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT)
Enrollment
132 pts
Location
Canada
Sponsor
University Health Network, Tor...
NCT06826924
Recruiting
7-Days Water-Only Fasting Trial in Prostate Cancer
Enrollment
10 pts
Location
United States
Sponsor
Sidney Kimmel Comprehensive Ca...
NCT06981377
Recruiting
PRostate Cancer Plasma Integrative Multi-modal Evaluation
Enrollment
800 pts
Location
Italy
Sponsor
Santa Chiara Hospital
NCT06854250 Phase 2
Recruiting
Prostate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate Cancer
Enrollment
104 pts
Location
China
Sponsor
Sun Yat-sen University